Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus

Go back to Amwell (AMWL) Reports Q4 Revenues Beat; Offers FY21 Revenue Mid-Point Outlook Below Consensus
(NYSE: AMWL) Delayed: 8.43 -0.07 (0.82%)
Previous Close $8.50    52 Week High
Open $8.53    52 Week Low
Day High $8.89    P/E N/A 
Day Low $8.39    EPS
Volume 82,900